Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Seattle Genetics, Takeda & Millennium begin phase-III Aethera trial of brentuximab vedotin for post-transplant Hodgkin lymphoma
Pharmabiz
Saturday, April 10, 2010 - 12:45pm
tags:
Seattle Genetics, Takeda, brentuximab vedotin, Hodgkin's lymphoma
Bristol-Myers Has New CFO, Strong Pipeline
Investors Business Daily
Saturday, April 10, 2010 - 12:35pm
tags:
Bristol-Myers Squibb, Dapagliflozin, coagulants
FDA Panel Deals Blow to Forest
Yahoo/Zacks
Saturday, April 10, 2010 - 12:20pm
tags:
Forest Labs, Daxas, COPD
Finkelstein Thompson LLP Announces Investigation of Medivation, Inc.
Yahoo/Business Wire
Saturday, April 10, 2010 - 12:18pm
tags:
Medivation, dimebon, Alzheimer's disease, investors
Double Your Biotech Returns! Really!
Motley Fool
Saturday, April 10, 2010 - 12:16pm
tags:
investors, biotech, ETFs
Inovio, Drexel, Penn and Cheyney get grant to develop hepatitis C vaccine Read more: Inovio, Drexel, Penn and Cheyney get grant to develop hepatitis C vaccine - Philadelphia Business Journal:
bizjournals.com
Saturday, April 10, 2010 - 12:15pm
tags:
Inovio, hepatitis C
Company Interview: Ligand Pharmaceuticals Inc. - John L. Higgins, President And CEO
Yahoo/Wall St. Transcript
Saturday, April 10, 2010 - 12:13pm
tags:
Ligand
Celgene (analysis)
Investor's Business Daily
Saturday, April 10, 2010 - 12:12pm
tags:
Celgene, anemia, cancer, Chron's Disease
Abbott a Step Closer to FACT
Yahoo/Zacks
Saturday, April 10, 2010 - 12:10pm
tags:
Abbott Laboratories, Facet Biotech, daclizumab, multiple sclerosis, Biogen Idec
Breast Cancer Drug T-DM1 Expected To Deliver Exciting Data In First Half Of 2010; Roche Expected To File For NDA
Yahoo/Wall St. Transcript
Saturday, April 10, 2010 - 11:44am
tags:
T-DM1, Roche, breast cancer
Cell's Pixantrone Denied Approval
Yahoo/Zacks
Saturday, April 10, 2010 - 11:41am
tags:
Cell Therapeutics, Pixuvri, non-Hodgkin's lymphoma
Celgene (CELG) Is A Top-Growth Biotech Stock; High P/E Multiple And Global Expansion Of Its Myeloma Franchise And REVLIMID Makes It A Top Stock Pick
Yahoo/Wall St. Transcript
Saturday, April 10, 2010 - 11:39am
tags:
Celgene, Revlimid, Multiple Myeloma
Roche Aims to Expand Rituxan Label
Yahoo/Zacks
Saturday, April 10, 2010 - 11:37am
tags:
Roche, Rituxan, PRIMA, follicular lymphoma
SciClone rallies on upgrade; drug indices diverge
Marketwatch
Friday, April 9, 2010 - 11:33am
tags:
SciClone, drug stocks
Cephalon finishes acquisition of drugmaker Mepha
Businessweek
Friday, April 9, 2010 - 11:32am
tags:
Mepha, Cephalon, M&A
Johnson & Johnson (NYSE: JNJ): First Quarter 2010 Earnings Preview
iStockAnalyst
Friday, April 9, 2010 - 11:30am
tags:
earnings, JNJ
Sanofi opens R&D center in China
Fierce Biotech
Friday, April 9, 2010 - 11:28am
tags:
R&D, China, Sanofi
Lawyer for female Novartis workers says they are cheated but company denies claim in NYC trial
SF Examiner, CA
Friday, April 9, 2010 - 11:28am
tags:
Novartis, discrimination
Celgene says stem cell therapy met safety goal
Yahoo/AP
Friday, April 9, 2010 - 11:27am
tags:
Celgene, stem cells, Crohn's Disease
Boston Scientific Mulls Sale of Two Units
TheStreet.com
Friday, April 9, 2010 - 11:25am
tags:
M&A, Boston Scientific, Abbott Laboratories, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.